Relapse of Intermediate or High-Grade (unfavorable) Non-Hodgkin’s Lymphoma as a Low-Grade (favorable) Non-Hodgkin’s Lymphoma: Report of Four Cases

David R. Head(University of Southern California), Lizardo Cerezo(Orlando Regional Medical Center), James Avakian(University of Utah), Carl R. Kjeldsberg(University of Oklahoma Health Sciences Center)

American Journal of Clinical Pathology

January 1, 1988

10.1093/ajcp/89.1.106

Cited by 14

Related Papers

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

|Blood|2000|1.6k

Age and acute myeloid leukemia

|Blood|2006|1.4k

Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study

|Blood|1997|869

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

|Journal of Clinical Oncology|1990|786

Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia

|New England Journal of Medicine|1991|722